{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:57:04Z","timestamp":1761947824562},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.humpath.2012.04.012","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T21:16:31Z","timestamp":1346274991000},"page":"2354-2359","source":"Crossref","is-referenced-by-count":6,"title":["Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia"],"prefix":"10.1016","volume":"43","author":[{"given":"Daniela","family":"Hoehn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2012.04.012_bb0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMc061565","article-title":"Imatinib and altered bone and mineral metabolism","volume":"355","author":"Tournis","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2012.04.012_bb0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMc061565","article-title":"Imatinib and altered bone and mineral metabolism","volume":"355","author":"Owen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2012.04.012_bb0015","first-page":"628","article-title":"Imatinib and altered bone and mineral metabolism","volume":"355","author":"Joensuu","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2012.04.012_bb0020","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1182\/blood-2007-07-104281","article-title":"Long-term imatinib therapy promotes bone formation in CML patients","volume":"111","author":"Fitter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.04.012_bb0025","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa051140","article-title":"Altered bone and mineral metabolism in patients receiving imatinib mesylate","volume":"354","author":"Berman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2012.04.012_bb0030","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1056\/NEJMc062388","article-title":"Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism","volume":"355","author":"Grey","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2012.04.012_bb0035","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood-2004-10-3967","article-title":"Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib","volume":"105","author":"Dewar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.04.012_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1440-1711.2004.01296.x","article-title":"Imatinib inhibits the functional capacity of cultured human monocytes","volume":"83","author":"Dewar","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.humpath.2012.04.012_bb0045","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2403071","article-title":"Imatinib inhibits the in vitro development of the monocyte\/macrophage lineage from normal human bone marrow progenitors","volume":"17","author":"Dewar","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2012.04.012_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4161\/cc.4.7.1788","article-title":"Inhibition of c-fms by imatinib: expanding the spectrum of treatment","volume":"4","author":"Dewar","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2012.04.012_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.taap.2011.04.019","article-title":"Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats","volume":"254","author":"Nurmio","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.humpath.2012.04.012_bb0060","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1359\/jbmr.070719","article-title":"Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms","volume":"22","author":"O'Sullivan","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.humpath.2012.04.012_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.exphem.2008.12.008","article-title":"Effects of imatinib mesylate in osteoblastogenesis","volume":"37","author":"Tibullo","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.humpath.2012.04.012_bb0070","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1182\/blood-2005-09-3568","article-title":"Imatinib as a potential antiresorptive therapy for bone disease","volume":"107","author":"Dewar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.04.012_bb0075","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood-2009-08-237404","article-title":"Dysregulation of bone remodeling by imatinib mesylate","volume":"115","author":"Vandyke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.04.012_bb0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00774-010-0203-2","article-title":"Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate","volume":"28","author":"Yang","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.humpath.2012.04.012_bb0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.20380","article-title":"Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia","volume":"101","author":"Bueso-Ramos","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2012.04.012_bb0135","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.leukres.2010.01.005","article-title":"Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study","volume":"34","author":"Teman","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2012.04.012_bb0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/path.1700800223","article-title":"Histological assessment of osteoporosis by iliac crest biopsy","volume":"80","author":"Beck","year":"1960","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.humpath.2012.04.012_bb0100","first-page":"70","article-title":"Histomorphometric analysis of normal bone from the iliac crest","volume":"86","author":"Melsen","year":"1978","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"10.1016\/j.humpath.2012.04.012_bb0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00974045","article-title":"Osteolytic lesion in chronic myelogenous leukemia (CML). Initial manifestation of blastic crisis?","volume":"8","author":"Oppermann","year":"1979","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.humpath.2012.04.012_bb0110","first-page":"610","article-title":"Osteolytic lesion in chronic myelogenous leukaemia","volume":"111","author":"Frydecka","year":"1984","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"10.1016\/j.humpath.2012.04.012_bb0115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(00)80314-1","article-title":"Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C","volume":"33","author":"Solis-Herruzo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2012.04.012_bb0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700910231","article-title":"Quantitative observations on mineralised and unmineralised bone in chronic renal azotaemia and intestinal malabsorption syndrome","volume":"91","author":"Garner","year":"1966","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.humpath.2012.04.012_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jcp.42.8.814","article-title":"Variation in histomorphometric estimates across different sites of the iliac crest","volume":"42","author":"Moore","year":"1989","journal-title":"J Clin Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T06:11:25Z","timestamp":1562134285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817712001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0046817712001499"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2012.04.012","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}